Section Arrow
ALLR.NASDAQ
- Allarity Therapeutics
(Financial Status)
Quotes are at least 15-min delayed:2024/05/14 03:07 EDT
Last
 0.796
+0.0049 (+0.62%)
Day High 
0.8443 
Prev. Close
0.7911 
1-M High
Volume 
3.60M 
Bid
0.783
Ask
0.8063
Day Low
0.771 
Open
0.78 
1-M Low
0.71 
Market Cap 
2.04M 
Currency USD 
P/E -- 
%Yield
10-SMA 1.02 
20-SMA 1.27 
50-SMA 4.22 
52-W High 315.92 
52-W Low 0.71 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-205.20/--
Enterprise Value
3.12M
Balance Sheet
Book Value Per Share
-1.74
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
NVAXNovavax13.11+4.23+47.64%-- 
DNAGinkgo Bioworks Holdings0.8407+0.0798+10.49%-- 
ACIUAC Immune SA3.3+0.99+42.86%-- 
JAGXJaguar Health0.290795-0.001305-0.45%-- 
TVGNTevogen Bio Holdings1+0.0155+1.57%-- 
Quotes are at least 15-min delayed:2024/05/14 03:07 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.